<DOC>
	<DOCNO>NCT01807663</DOCNO>
	<brief_summary>Determing optimal time ventilator disconnection challenge acute chronic neuromuscular disease . In one case helpful weanning ventilator optimize daytime ventilation severe patient . The investigator propose validate new non invasive tool monitoring respiratroy parameter neuromuscular patient acute chronic condition .</brief_summary>
	<brief_title>Validation Dynamic Evaluation Tool Respiratory Failure</brief_title>
	<detailed_description>Context : Mechanical ventilation transform prognosis neuromuscular diseases whether acute chronic disease . The available tool estimate severity respiratory insufficiency indicate follow efficiency mechanical ventilation base blood gaze exploration , test respiratory function sleep evaluation . These tool give either limited information , difficulty applicable patient heavily handicap except hospitalization . In patient mechanical ventilation , sometimes difficult know daily optimal time ventilation . The respiratory event generally recognize unspecific ( headache , drowsiness , dyspnoea , etc . ) identify blood gaze abnormality ( hypercapnia . In acute setting , treble go raise problem wean mechanical ventilation optimal moment extubation without risk reintubation . These problem identical concern evaluation degree ventilatory autonomy home care . The development method estimate autonomy thus fundamental . Objectives : objective project validate non-invasive system measure acquisition respiratory parameter , incorporate transmission system work `` wireless '' technology allow remote monitoring patient . The secondary objective determine parameter success wean use device neuromuscular patient intubated respiratory failure acute set determine optimal time free breathing possibility patient ventilate chronic way home . Methods : After validation device 10 healthy subject , continuous acquisition ventilatory data mean Teleresp system compare measure transcutaneous PCO2 , SaO2 arterial gazometry end free breath trial 40 acute chronic neuromuscular patient . Selection criterion : Healthy volunteer Patients affect acute neuromuscular pathology start wean invasive ventilation ( Guillain Barré myasthenia ) . Patients affect neuromuscular pathology home ventilate diurnal night-way invasive interface ( respiratory autonomy least 1:00 ) . Number patient , center : 10 healthy volunteer 40 patient hospitalize intensive care unit home ventilation unit Raymond Poincaré hospital . Total duration study : 19 month</detailed_description>
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<criteria>Healthy volonteers Man woman 18 year Realization preliminary medical examination Patient sign inform write consent Major healthy subject , present chronic pathology chronic patient Chronic patient Man woman 18 year Affected neuromuscular pathology Realization preliminary medical examination Patient stable state time study least 1 month Ventilated invasive invasive way diurnal nightperiod . Respiratory autonomy &gt; 1:00 Patient sign inform write consent Acute Patients Man woman 18 year Affected syndrome Guillain block aigue phase require invasive ventilation affect myasthenia generalized myasthénique crisis require invasive ventilation . Realization preliminary medical examination Patient phase neurological recovery Vital Capacity &gt; 15 ml / kg Respiratory Autonomy &gt; 1:00 Patient sign lit ( enlighten ) write consent Healthy volonteers subject refuse participate study subject guardianship guardianship Pregnant breastfeed Woman Chronic patient Patient refuse participate study Patient guardianship guardianship Pregnant breastfeed Woman Patients ventilate night Clinically significant bronchial Dimensions ( Congestion ) Required oxygen therapy Acute patient Patient refuse participate study Patient subject guardianship guardianship Pregnant breastfeed Woman Clinically significant bronchial Dimensions ( Congestion ) Required oxygen therapy FIO2 &gt; 40 % PEP &gt; 5 cm H2O State shock</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>neuromuscular disease</keyword>
</DOC>